IADR Abstract Archives

Periosteal Pedicle Flap - Plateletes Rich Fibrin for Periodontal Regeneration

Objectives: The use of autogenous graft materials has been recorded to be a gold standard in regenerative therapy. This study directed toward evaluation of 2 autogenous regenerative materials, marginal periosteal pedicle graft (MPP) and platelet rich fibrin (PRF) as a membrane barriers for treating intrabony defects. In spite of its reported significant clinical outcomes, the limited availability of the periosteum makes it necessary to evaluate other autogenous alternatives such as PRF that could offer predictable outcomes.
Methods: In a split mouth design10 patients with severe chronic periodontitis and at least 2 sites ≥4 mm intrabony defect had participated in this randomized clinical study. Subjects were randomly divided into2 groups, Group 1 (MPP) defect coverage with xenograft defect fill, Group 2 (PRF) defect coverage with xenograft defect fill. Clinical and radiographic measurements were at 3, 6 and 9 months postoperatively.
Results: Clinical attachment gain was 2.7 ± 1.1, 3 ± 1.3 for MPP and PRF respectively. Intrabony reduction was-1.1 ± 0.3 and -1.4 ± 0.7 for MPP and PRF respectively.
Conclusions: Both platelets rich fibrin and marginal periosteal pedicle graft have a significant healing potential as a regenerative technique in treating periodontal defects. Membrane exposure was not likely to develop following PRF and MPP grafts suggesting a more tissue friendly behavior of these two autogenous grafts.
Division: IADR/AADR/CADR General Session
Meeting: 2015 IADR/AADR/CADR General Session (Boston, Massachusetts)
Location: Boston, Massachusetts
Year: 2015
Final Presentation ID: 3706
Abstract Category|Abstract Category(s): Dental Materials 4: Clinical Trials
Authors
  • Khattab, Doaa  ( Ain Shams University , cairo , Egypt )
  • Abd El-ghaffar, Khald  ( Ain Shams University , Cairo , Egypt )
  • Gamal, Ahmed  ( Ain Shams University , cairo , Egypt )
  • Eldessouky, Hadir  ( Ain Shams University , cairo , Egypt )
  • Financial Interest Disclosure: NONE
    SESSION INFORMATION
    Poster Session
    Clinical Trials III
    Saturday, 03/14/2015 , 03:30PM - 04:45PM
    TABLES
    The mean differences (reduction or gain) in different clinical parameters, standard deviation (SD) values and results of comparison between the two groups.
    Period MPP PRF Difference between the two groups P-Value
    PD (mm) Pre – 3 m -2.50 ± 0.71 -1.80 ± 0.63 0.70 ± 0.67 0.020*
    Pre – 6 m -2.80 ± 0.42 -1.90 ± 0.88 0.90 ± 0.99 0.021*
    Pre – 9 m -3.00 ± 0.82 -2.10 ± 1.10 0.90 ± 1.20 0.047*
    CAL (mm) Pre – 3 m -1.90 ± 0.99 -2.20 ± 1.40 0.30 ± 1.77 0.550
    Pre – 6 m -2.20 ± 1.03 -2.80 ± 1.14 0.60 ± 1.78 0.340
    Pre – 9 m -2.70 ± 1.06 -3.00 ± 1.25 0.30 ± 2.00 0.723
    GR (mm) Pre – 3 m 0.70 ± 0.82 -0.30 ± 1.06 1.00 ± 1.70 0.102
    Pre – 6 m 0.60 ± 1.07 -0.80 ± 1.32 1.40 ± 1.96 0.056
    Pre – 9 m 0.50 ± 0.85 -0.60 ± 1.35 1.10 ± 1.79 0.088
    PI Pre – 3 m -0.20 ± 0.79 0.00 ± 0.47 0.20 ± 0.92 0.480
    Pre – 6 m -0.20 ± 0.79 0.00 ± 0.47 0.20 ± 0.92 0.480
    Pre – 9 m -0.30 ± 0.82 -0.10 ± 0.32 0.20 ± 0.79 0.414
    SBI Pre – 3 m -0.20 ± 1.03 -0.40 ± 0.52 0.20 ± 1.03 0.527
    Pre – 6 m -0.10 ± 0.88 -0.50 ± 0.85 0.40 ± 1.43 0.395
    Pre – 9 m -0.30 ± 0.95 -0.50 ± 1.08 0.20 ± 1.48 0.566
    Values are mean ± SD, *: Significant at P ≤ 0.05
    IMAGES